Core Scientific, Inc.

Core Scientific, Inc.

CORZ
Core Scientific, Inc.US flagNASDAQ Global Select
17.89
USD
-0.01
- -
5.75BMarket Cap

Total Valuation

Core Scientific, Inc. carries a market capitalization of 5.75B, placing it among publicly traded companies globally. Its enterprise value stands at 10.71B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap5.75B
Enterprise Value10.71B

Share Statistics

Core Scientific, Inc. currently has 319.59M shares outstanding.

Shares Outstanding319.59M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 18.69, and the price-to-book ratio stands at -3.38.

PE RatioN/A
PS Ratio18.69
PB Ratio-3.38
P/TBV Ratio-3.09
P/FCF Ratio4.58
P/OCF Ratio15.96

Enterprise Valuation

EV / Sales24.32
EV / EBITDAN/A
EV / EBITN/A
EV / FCF5.34

Financial Position

Core Scientific, Inc. maintains a current ratio of 0.89, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -177.65, indicating conservative leverage, while an interest coverage ratio of -26.98 demonstrates limited ability to service its debt obligations.

Current Ratio0.89
Quick Ratio0.79
Debt / Equity-177.65
Debt / EBITDA-32.79
Interest Coverage-26.98

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-39.59
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)-131.95
Revenue Per EmployeeN/A
Employee CountN/A
Inventory TurnoverN/A

Taxes

Over the trailing twelve months, Core Scientific, Inc. has paid 2.73M in income taxes, reflecting an effective tax rate of 0.04.

Income Tax2.73M
Effective Tax Rate0.04

Stock Price Statistics

Core Scientific, Inc.'s stock has gained approximately 31.35095% over the past 52 weeks. The 50-day moving average sits at 20.85, while the 200-day moving average is 19.69.

Beta (5Y)N/A
52-Week Price Change31.35095%
50-Day Moving Average20.85
200-Day Moving Average19.69
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Core Scientific, Inc. generated 440.31M in revenue and converted that into -1.43B in net income, yielding earnings per share of -4.00. EBITDA reached -131.06M, while operating income came in at -205.89M.

Revenue440.31M
Gross Profit124.81M
Operating Income-205.89M
Pretax Income-1.43B
Net Income-1.43B
EBITDA-131.06M
EBIT-205.89M
Earnings Per Share (EPS)-4.00

Balance Sheet

Core Scientific, Inc. holds 1.77B in cash and equivalents against 4.30B in total debt, resulting in a net debt position of 2.53B. Total book value stands at -2.42B, with working capital of -294.15M providing operational flexibility.

Cash & Cash Equivalents1.77B
Total Debt4.30B
Net Debt2.53B
Equity (Book Value)-2.42B
Book Value Per Share-7.57
Working Capital-294.15M

Cash Flow

Core Scientific, Inc. produced 515.80M in operating cash flow over the past twelve months. After subtracting -1.48B in capital expenditures, free cash flow totaled -967.97M - equivalent to -3.01 per share.

Operating Cash Flow515.80M
Capital Expenditures-1.48B
Free Cash Flow-967.97M
FCF Per Share-3.01

Margins

Core Scientific, Inc. operates with a gross margin of 28.35, reflecting its pricing power and cost economics. The operating margin of -46.76 and net profit margin of -325.31 provide insight into operational efficiency.

Gross Margin28.35
Operating Margin-46.76
Pretax Margin-324.69
Profit Margin-325.31
EBITDA Margin-29.76

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-38.70
FCF Yield21.84

Scores

Core Scientific, Inc. posts an Altman Z-Score of -1.05, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-1.05